ConductScience.org, home

Paper41008599

The Emerging Role of Mitochondrial Dysfunction in Thyroid Cancer: Mediating Tumor Progression, Drug Resistance, and Reshaping of the Immune Microenvironment.

Zhang Y and 6 others. Biomolecules, 2025. Cited by 6 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The Emerging Role of Mitochondrial Dysfunction in Thyroid Cancer: Mediating Tumor Progression, Drug Resistance, and Reshaping of the Immune Microenvironment. Papers, record 41008599. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41008599

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Emerging Role of Mitochondrial Dysfunction in Thyroid Cancer: Mediating Tumor Progression, Drug Resistance, and Reshaping of the Immune Microenvironment.
PubMed
Journal
Biomolecules
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.82, provisional
iCite
Revised in PubMed
2026-03-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang YYating
2Han HHengtong
3Zhang TTingting
4Zhang TTianying
5Ma LLibin
6Yang ZZe
7Zhao YYongxun

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tumor MicroenvironmentMajor topic
Thyroid NeoplasmsMajor topic
MitochondriaMajor topic
Drug Resistance, NeoplasmMajor topic
Humans
Animals
Disease Progression

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No. Ldyyyn2021-120; No. Ldyyyn2020-98; No. Ldyyyn2021-30Yong-xun ZhaoPubMed
No. 17JR5RA272; No. 22JR5RA923Yong-xun ZhaoPubMed

Source PubMed

Download CSV of grants

References199

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128575805Niclosamide induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in human thyroid cancer in vitro.Biomed Pharmacother2017https://conductscience.org/library/papers/28575805PubMed
239581298The toxicological role of Myricetin in the progression of human anaplastic thyroid cancer SW1736 cell line.Food Chem Toxicol2025https://conductscience.org/library/papers/39581298PubMed
327597941Stem Cell-Derived Extracellular Vesicles and Immune-Modulation.Front Cell Dev Biol2016https://conductscience.org/library/papers/27597941PubMed
430366131Polydopamine-coated Au-Ag nanoparticle-guided photothermal colorectal cancer therapy through multiple cell death pathways.Acta Biomater2019https://conductscience.org/library/papers/30366131PubMed
534761353Mitochondrial DNA Mutagenesis: Feature of and Biomarker for Environmental Exposures and Aging.Curr Environ Health Rep2021https://conductscience.org/library/papers/34761353PubMed
619835928Thyroid cancer and inflammation.Mol Cell Endocrinol2010https://conductscience.org/library/papers/19835928PubMed
739667698SEMA3C promotes thyroid cancer via the Wnt/β-catenin pathway.Exp Cell Res2025https://conductscience.org/library/papers/39667698PubMed
830118906Hypericin-assisted photodynamic therapy against anaplastic thyroid cancer.Photodiagnosis Photodyn Ther2018https://conductscience.org/library/papers/30118906PubMed
931209921Inhibition of mitochondrial respiration by tigecycline selectively targets thyroid carcinoma and increases chemosensitivity.Clin Exp Pharmacol Physiol2019https://conductscience.org/library/papers/31209921PubMed
1038812059Mitochondrial quality control in human health and disease.Mil Med Res2024https://conductscience.org/library/papers/38812059PubMed
1134880425Molecular mechanisms and consequences of mitochondrial permeability transition.Nat Rev Mol Cell Biol2022https://conductscience.org/library/papers/34880425PubMed
1235464760Thyroid Cancer-Associated Mitochondrial DNA Mutation G3842A Promotes Tumorigenicity via ROS-Mediated ERK1/2 Activation.Oxid Med Cell Longev2022https://conductscience.org/library/papers/35464760PubMed
1330049712Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis.EMBO J2018https://conductscience.org/library/papers/30049712PubMed
1426942671Mitochondria and Cancer.Mol Cell2016https://conductscience.org/library/papers/26942671PubMed
1515800626Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death.Nature2005https://conductscience.org/library/papers/15800626PubMed
1638288744Recent insights into the control of mitochondrial fission.Biochem Soc Trans2024https://conductscience.org/library/papers/38288744PubMed
1739815317A review of the pathogenesis of mitochondria in breast cancer and progress of targeting mitochondria for breast cancer treatment.J Transl Med2025https://conductscience.org/library/papers/39815317PubMed
1837634662Curcumin induces mitophagy by promoting mitochondrial succinate dehydrogenase activity and sensitizes human papillary thyroid carcinoma BCPAP cells to radioiodine treatment.Toxicol In Vitro2023https://conductscience.org/library/papers/37634662PubMed
1934158007Pyruvate carboxylase promotes thyroid cancer aggressiveness through fatty acid synthesis.BMC Cancer2021https://conductscience.org/library/papers/34158007PubMed
2027277113Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype.J Transl Med2016https://conductscience.org/library/papers/27277113PubMed

See all 199 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42668997PUM1 Promotes HCC Cell Proliferation and Inhibits Mitochondria‑mediated Apoptosis, Accompanied by Activation of the PI3K-AKT Pathway.J Hepatocell Carcinoma2026https://conductscience.org/library/papers/42668997PubMed
42488502Autophagy in thyroid cancer: stage-dependent switch, mutation-specific regulation, and therapeutic targeting.Oncol Rev2026https://conductscience.org/library/papers/42488502PubMed
42436980Mitochondrial DNA mutations drive tumor heterogeneity in papillary thyroid carcinoma.iScience2026https://conductscience.org/library/papers/42436980PubMed
42394690Exposure to multiple metallic elements and risk of thyroid tumors: insights from elemental profiling, diet, and molecular characteristics plasma levels of metallic elements.Front Oncol2026https://conductscience.org/library/papers/42394690PubMed
42222166Functionalized nanomedicines for co-targeting of multiple pathways to efficiently treat thyroid cancer: prospects and challenges.Front Pharmacol2026https://conductscience.org/library/papers/42222166PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41008599

GET https://conductscience.org/api/papers/v1/41008599/references?page=2